14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.83 $2.63 Thursday, 25th Apr 2024 CGEN stock ended at $1.90. This is 0.524% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.88% from a day low at $1.89 to a day high of $2.02.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
Aug 20, 2020 $18.83 $18.92 $18.01 $18.56 1 762 435
Aug 19, 2020 $17.89 $19.89 $17.83 $18.95 2 578 901
Aug 18, 2020 $18.03 $18.10 $17.34 $17.81 1 255 233
Aug 17, 2020 $17.42 $18.16 $17.08 $18.00 855 891
Aug 14, 2020 $17.69 $17.75 $16.86 $17.20 1 355 919
Aug 13, 2020 $17.55 $18.02 $17.33 $17.55 1 671 700
Aug 12, 2020 $16.65 $17.79 $16.50 $17.55 2 013 420
Aug 11, 2020 $16.34 $16.94 $16.09 $16.28 999 453
Aug 10, 2020 $16.08 $16.69 $15.97 $16.39 1 050 736
Aug 07, 2020 $16.36 $17.10 $16.04 $16.33 1 359 610
Aug 06, 2020 $16.39 $17.14 $15.86 $16.46 1 759 479
Aug 05, 2020 $16.17 $16.65 $15.76 $16.33 1 259 971
Aug 04, 2020 $15.42 $16.09 $15.33 $16.07 1 544 969
Aug 03, 2020 $14.53 $16.25 $14.42 $15.82 2 491 117
Jul 31, 2020 $15.35 $15.46 $14.19 $14.41 1 177 395
Jul 30, 2020 $14.10 $15.57 $14.10 $15.44 1 301 790
Jul 29, 2020 $14.50 $14.66 $14.01 $14.28 979 135
Jul 28, 2020 $14.69 $14.82 $14.37 $14.40 719 163
Jul 27, 2020 $14.64 $14.98 $14.04 $14.82 1 165 980
Jul 24, 2020 $14.50 $14.60 $13.85 $14.16 1 884 280
Jul 23, 2020 $14.98 $15.60 $14.51 $14.63 985 638
Jul 22, 2020 $16.00 $16.01 $15.10 $15.27 1 372 600
Jul 21, 2020 $16.92 $17.11 $16.01 $16.04 1 245 400
Jul 20, 2020 $16.17 $16.95 $15.67 $16.85 1 247 300
Jul 17, 2020 $15.22 $16.25 $15.00 $16.01 1 046 300
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT